We didn't ask women to guess whether Eve was working. We measured it.
In a 30-day consumer trial with 60 women aged 45–70 — spanning both perimenopause and menopause — we tracked nine outcomes. Here's what the data showed.
Results - Weight & Waist Reduction
Results - Perimenopause and Menopause Symptoms
Why the Results Differ by Stage
Perimenopause and menopause aren't the same hormonal state — and the results reflect that. Women in perimenopause are still experiencing fluctuating oestrogen, which affects water retention, cortisol response, and metabolic rate differently to post-menopausal women, whose oestrogen has stabilised at a lower baseline.
This is why generic meal replacement shakes — designed for a 30-year-old in a calorie deficit — don't work the same way for women over 45. Eve Biology was formulated with this distinction in mind.
Why These Outcomes Happen
Weight and waist reduction High-quality protein supports muscle retention during a calorie deficit — critical in menopause when muscle loss accelerates. Preserving muscle keeps your metabolic rate higher, making fat loss more sustainable.
Anxiety improvement (95.5%) Ashwagandha KSM-66 — the most clinically studied form of ashwagandha — works directly on the HPA axis, the system that governs your cortisol response. In menopause, chronic HPA activation keeps cortisol elevated, driving anxiety, irritability, and stress sensitivity. KSM-66 has been shown to reduce cortisol levels and support the body's ability to regulate its own stress response — which is why 95.5% of women in our trial reported meaningful improvement in anxiety.
Sleep improvement (85%)
Cortisol and melatonin are inversely related — when cortisol stays elevated into the evening, sleep quality suffers. Ashwagandha KSM-66 supports the body's ability to down-regulate cortisol as the day progresses, helping restore the natural rhythm that menopause disrupts. Better cortisol regulation in the evening means better sleep at night.
Brain fog improvement (85%) Ginkgo Biloba supports cerebral blood flow — increasing the delivery of oxygen and glucose to the brain. In menopause, declining oestrogen reduces cerebrovascular circulation, which is a key driver of brain fog and poor concentration. By supporting blood flow to the brain alongside protein and fibre for blood sugar stability, Eve Biology addresses brain fog from two directions simultaneously.
Hot flashes and night sweats (71%) Hot flashes and night sweats are triggered by the hypothalamus becoming hypersensitive to small changes in body temperature — a direct consequence of falling oestrogen. Ashwagandha KSM-66 helps regulate the HPA axis and reduce the cortisol spikes that amplify thermoregulatory sensitivity, making the hypothalamus less reactive. Results vary by hormonal stage — which is why the peri/menopause split in our trial reflects a meaningful difference in response.
Bloating improvement (72.5%) Eve Biology contains Actilight® — a clinically proven prebiotic fibre with a short-chain structure (DP 3-5) that selectively stimulates the growth of bifidobacteria in the gut, even at a low dose of 2.5g per day. In menopause, falling oestrogen reduces gut microbiome diversity, disrupting digestion and driving bloating. Actilight® directly addresses this by rebalancing gut microbiota, improving bowel function and gastrointestinal comfort — without the artificial sweeteners and fillers that commonly aggravate symptoms in other shakes.
Energy improvement (87.5%) Sustained energy in menopause depends on more than avoiding a calorie deficit. Eve Biology supports energy production directly — with iron and a full B vitamin complex to fuel cellular energy pathways — while Actilight® prebiotic fibre improves nutrient absorption in the gut, meaning the vitamins and minerals you consume are actually extracted and used. Ashwagandha KSM-66 addresses the cortisol-driven fatigue that disrupts sleep and depletes the adrenal system. The result is energy supported at three levels: production, absorption, and recovery — without stimulants.
About the Trial
60 women aged 45–70, split across perimenopause and post menopause stages, completed a 30-day consumer trial replacing breakfast and lunch with The Rebalancing Shake Monday to Friday for 4 weeks. Outcomes were self-reported at day 0 and day 30 across nine symptom and body composition measures. We wanted to keep the trial realistic. We didn't ban alcohol or treats. We did encourage women to do 30 minutes walking a day as a minimum activity benchmark.
How We Measured It
At day 0 and day 30, each participant completed a structured self-assessment covering:
- Body composition — weight, waist circumference, and height recorded at both intervals
- Eight symptoms — anxiety, brain fog, hot flashes, sleep disruption, night sweats, PMT, energy, and bloating — each rated on a five-point severity scale from "I don't suffer from this" to "severe, causing significant disruption to daily life"
- Digestive health — bowel movement frequency as a gut health indicator
- Context — menopause stage (peri or menopause), HRT use, and prior shake experience
Results were anonymised and analysed by stage. The severity scale allowed us to measure meaningful improvement even where symptoms didn't disappear entirely — a reduction from severe to mild is a real outcome.
30 Day Baseline Tracker
Build your baseline profile - we'll send you a copy to keep. In 30 days we'll send you a reminder to add your current stats to the profile. That way, whatever it is you've been doing you'll know what's changing.
LOG MY BASELINEWhat Women Said
On The Trial Women Just Had The Shake
Todays Eve Biology Customers Get More
When 60 women completed our consumer trial, they had one thing: The Rebalancing Shake.
No nutritionist-designed recipes. No meal guides. No support programme.
The results you've seen above were achieved with the shake alone.
Since the trial, we've built out everything we wished those women had access to — because we saw what was possible without it, and we wanted to know what happens when women are properly supported.
Every Eve Biology customer now gets:
- Nutritionist-designed recipes built around the shake and menopause nutrition principles — browse the recipes
- Diet guides for perimenopause and menopause
- A structured 4-week plan — the same format our trial was built around
- Symptom guides covering the main menopause symptoms — explore the guides
- 5 basic exercises for women over 40 - and an easy week by week plan to make them habitual
The trial set the baseline. What you're starting with is the full picture.
Frequently Asked Questions
How much weight did women lose in the Eve Biology trial?
On average, women lost 5.36 lbs over 30 days. Women in perimenopause lost an average of 7.3 lbs, while women in menopause lost an average of 3.43 lbs.
Who took part in the Eve Biology trial?
Women aged 45–70, spanning both perimenopause and menopause, completed a 30-day consumer trial using The Rebalancing Shake as a daily meal replacement. Our volunteers were friends of friends, some colleagues and referrals.
Did the Eve Biology shake help with menopause symptoms?
Yes. In a 30-day consumer trial, 95.5% of women reported improvement in anxiety, 85% reported improvement in brain fog and sleep, 71% reported improvement in hot flashes and night sweats, and 87.5% reported improvement in energy levels.
Why are the results different for perimenopause and menopause?
The 4-week structure is a starting point. Many women continue with one shake a day indefinitely as part of a balanced diet — that's a healthy, sustainable approach.
Is this safe during perimenopause or menopause?
Perimenopause and menopause involve different hormonal states. Women in perimenopause are still experiencing fluctuating oestrogen, which affects water retention, cortisol response, and metabolism differently to post-menopausal women. This is why results vary by stage.
How does The Rebalancing Shake help with bloating?
72.5% of women in the trial reported improvement in bloating. Eve Biology contains Actilight® — a clinically proven prebiotic fibre that selectively stimulates the growth of bifidobacteria in the gut. Falling oestrogen reduces gut microbiome diversity, which contributes to bloating. Actilight® directly rebalances gut microbiota to improve gastrointestinal comfort.
Is the Eve Biology trial clinically proven?
The results come from a 30-day consumer trial with 50 women aged 45–70, with outcomes self-reported at day 0 and day 30. While not a clinical study, the trial was structured to measure real-world outcomes across nine symptom and body composition measures.
Ready To Try It?
The trial used The Rebalancing Shake — available in Chocolate, Vanilla, and Strawberry.
SHOP EVE